Skip to main content

Closed

GLMD: Galmed Pharmaceuticals Ltd. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

16thpctl

Volume

0.18×avg

Market Cap

5.13MUSD

P/E Ratio

-0.3TTM

Div Yield

-ann

Galmed Pharmaceuticals Ltd.

GLMDNASDAQ·USD·Closed

Galmed Pharmaceuticals Ltd.

GLMDNASDAQ·USD·Closed

$0.62

+3.67%

$0.62

+$0.02 (3.67%)

52W Range

16thpctl

Volume

0.18×avg

Mkt Cap

5.13MUSD

P/E

-0.3TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings